Phenformin

CHEMBL170988 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

205.3 g/mol

LogP

-0.8

Phase

4

Phenformin is a biguanide-class antidiabetic agent that lowers blood glucose primarily by inhibiting hepatic gluconeogenesis and improving peripheral insulin sensitivity through activation of AMP-activated protein kinase (AMPK). Although withdrawn from most markets due to a high risk of lactic acidosis, it has garnered renewed research interest as a potential antineoplastic agent, particularly in melanoma, through its effects on cellular metabolism and mTOR pathway inhibition.

Peso molecular

205,2600 g/mol

LogP

-0,80

TPSA

103,00 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Diabetes tipo 2 Melanoma

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

N=C(N)NC(=N)NCCc1ccccc1

InChI

InChI=1S/C10H15N5/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H6,11,12,13,14,15)

Molecular Formula

C10H15N5

HBD / HBA

3 / 1

Enlaces Rotables

4

Átomos Pesados

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Phenformin is a biguanide-class antidiabetic agent that lowers blood glucose primarily by inhibiting hepatic gluconeogenesis and improving peripheral insulin sensitivity through activation of AMP-activated protein kinase (AMPK). Although withdrawn from most markets due to a high risk of lactic acidosis, it has garnered renewed research interest as a potential antineoplastic agent, particularly in melanoma, through its effects on cellular metabolism and mTOR pathway inhibition.

Yes, Phenformin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL170988. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 8249. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Phenformin en PillFYI

Estructura

Datos Rápidos

Fórmula: C10H15N5

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.